BMJ Oncology (BMJO)

BMJ Oncology is an open access journal with a mission to optimise cancer care and improve patient outcomes. The journal prioritises high quality original research and review papers across the broad spectrum of cancer research, investigation, treatment and practice. BMJ Oncology is a new BMJ journal that aims to optimise cancer patient care and improve outcomes. An open access, online format supports the global reach and impact of BMJ Oncology content. The journal invites oncology experts to submit high-quality original research and review papers. Publishing consideration will be extended to papers that provide sound science across the broad spectrum of cancer research, investigation, treatment and practice. BMJ Oncology aims to improve cancer outcomes by: Publishing a broad range of peer-reviewed articles that provide significant clinical, scientific and educational value Reaching a wide international audience through BMJ’s global recognition and clinical following Facilitating a close interaction between basic, translational and clinical sciences through publication and by fostering interdisciplinary research Provoking scientific debate and discussion Encouraging researchers, clinicians, patients and the public to engage with the journal content and contribute through social media and multimedia

BMJ Oncology (BMJO) is :-

• International, Peer-Reviewed, Open Access, Refereed, Oncology, Cancer Research, Clinical Medicine, Translational Medicine, Medical Education, Public Health , Online , Yearly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2752-7948, Established: 2022,
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE